跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG - HSA Drug Approval Details
Approvals
/
HSA
/
MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG
Approved
THERAPEUTIC
MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG
HETERO LABS LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Feb 19, 2016
Approval ID
9f17b8387c956003
Company
HETERO LABS LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
9f17b8387c956003
Drug Name
MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG
Product Name
MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG
Approval Number
SIN14954P
Approval Date
2016-02-19
Registrant
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Licence Holder
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, CHEWABLE
Route Of Administration
ORAL
Atc Code
R03DC03
Atc Item Name
montelukast
Pharma Manufacturer Name
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Active Ingredients
Montelukast Sodium 4.160 mg eqv Montelukast
4.000 mg
MONTELUKAST SODIUM 4.16 MG EQV MONTELUKAST
4 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 19, 2016
Approval ID
9f17b8387c956003
Type
Therapeutic
Back to HSA Approvals
